ID   414C2
AC   CVCL_DP60
SY   414C-2; HPS4292
DR   GEO; GSM1040276
DR   GEO; GSM1040346
DR   GEO; GSM1899767
DR   RCB; HPS4292
DR   SKIP; SKIP000822
DR   Wikidata; Q54602985
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=26997647;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 7,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
RX   PubMed=21460823; DOI=10.1038/nmeth.1591;
RA   Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S.,
RA   Hong H.-J., Nakagawa M., Tanabe K., Tezuka K.-i., Shibata T.,
RA   Kunisada T., Takahashi M., Takahashi J., Saji H., Yamanaka S.;
RT   "A more efficient method to generate integration-free human iPS
RT   cells.";
RL   Nat. Methods 8:409-412(2011).
//
RX   PubMed=22802639; DOI=10.1073/pnas.1209979109;
RA   Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N.,
RA   Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.;
RT   "Donor-dependent variations in hepatic differentiation from
RT   human-induced pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=26997647; DOI=10.1016/j.stemcr.2016.02.011;
RA   Ichiyanagi N., Fujimori K., Yano M., Ishihara-Fujisaki C., Sone T.,
RA   Akiyama T., Okada Y., Akamatsu W., Matsumoto T., Ishikawa M.,
RA   Nishimoto Y., Ishihara Y., Sakuma T., Yamamoto T., Tsuiji H.,
RA   Suzuki N., Warita H., Aoki M., Okano H.;
RT   "Establishment of in vitro FUS-associated familial amyotrophic lateral
RT   sclerosis model using human induced pluripotent stem cells.";
RL   Stem Cell Reports 6:496-510(2016).
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M.,
RA   Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M.,
RA   Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A.,
RA   Yamanaka S., Yoshida Y.;
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//